SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Many Parents on Obesity Meds Discuss Treatment With Kids

Parents often discuss using obesity medications and related weight or behavior changes with their children.

Menopause Symptoms Worse in Women With Abdominal Obesity

Women with abdominal obesity report a higher burden of certain menopausal symptoms and exhibit a distinct pattern of symptom interrelationships relative to women without abdominal obesity.

Can Lower-Dose Tirzepatide Keep Weight Off?

New trial data suggest some patients may maintain meaningful weight loss after stepping down from the maximum dose of tirzepatide.

Pesticides May Help Explain Rising Early-Onset CRC Rates

A study linked a common herbicide to rising early-onset colorectal cancer, using DNA methylation to trace lifelong exposures rather than relying on patient recall.

Restarting GLP-1s After Stopping: How to Counsel Patients

Many patients taking GLP-1 RAs for weight loss discontinue within the first year. How can clinicians support long-term success with these drugs?

Exclusive-FDA Drug Center Head Expected to Leave After Commissioner's Exit, Sources Say

The acting head of the U.S. Food and Drug Administration's drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty ⁠Makary...

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Latest News

Parents often discuss using obesity medications and related weight or behavior changes with their children.

Women with abdominal obesity report a higher burden of certain menopausal symptoms and exhibit a distinct pattern of symptom interrelationships relative to women without abdominal obesity.

New trial data suggest some patients may maintain meaningful weight loss after stepping down from the maximum dose of tirzepatide.

A study linked a common herbicide to rising early-onset colorectal cancer, using DNA methylation to trace lifelong exposures rather than relying on patient recall.

Many patients taking GLP-1 RAs for weight loss discontinue within the first year. How can clinicians support long-term success with these drugs?

The acting head of the U.S. Food and Drug Administration's drug center, Tracey Beth Hoeg, is expected to leave the agency just days after Commissioner Marty ⁠Makary...

News All Time

How Bariatric Surgery Shapes IBD Risk Over Time in Obesity

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

Acid Blockers May Worsen Gastro Effects of Weight-Loss Drugs

The dual-medication group shows a significantly higher risk for several conditions.

Longer Abstinence May Reduce Sperm Quality Over Time

Prolonged sperm storage may reduce motility and vitality through oxidative stress and DNA damage, thereby affecting fertility.

Why Patients Stop Treatment and How Clinicians Can Help

Medication adherence often declines over time, but targeted communication and simpler regimens may help improve long-term treatment outcomes.

Want to Know What Caused Cushing? Urine Tests Can Help

Urinary free cortisol expressed as times above the upper limit of normal is a strong discriminator between ectopic ACTH-dependent and pituitary Cushing syndrome, according to a Spanish study.

Hidden Sugar Traps Patients With Diabetes Should Recognize

Food labels are often misleading when it comes to glycemic impacts.

Previous Pregnancy Signals Lower Folic Acid Use

Women with previous pregnancies are consistently less likely than first-time mothers to take folic acid supplements before conception and during early pregnancy, a meta-analysis shows.

Oral Orforglipron Effective in Older Adults With Obesity

People over 65 taking once-daily oral orforglipron achieved substantial weight loss with a consistent safety profile, regardless of T2D status, in a post hoc ATTAIN trial analysis.

Refining Management Strategies for Patients With Endometriosis

Refining Management Strategies for Patients With Endometriosis

Toddler Has Menstrual Cycle at 17 Months

Clinicians ruled out precocious puberty before landing on a diagnosis of exclusion

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Recommended News For You

Enhanced CAR T cell therapy offers new strategy for lymphoma

How a California Oncologist Making $850k Spends Money

Smart exercise planning could boost recovery for people with cancer

Can taking vitamin D supplements every day lower the mortality rate from cancer?

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

Recommended Articles For You

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment 

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies 

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Minimally invasive prostate cancer treatment shows success in first patient

2.

Updates from the 2022 WHO classification of kidney epithelial tumors

3.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

4.

Severe obesity associated with reduced prevalence of recommended cancer screenings

5.

For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.

1.

What is Red Cell Distribution Width and Why Should You Care?

2.

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring

3.

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies

4.

Understanding Sideroblastic Anemia and its Symptoms 

5.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

5.

Current Scenario of Cancer- Q&A Session to Close the Gap

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot